Evidence map›Paper›PMID 41596425›Full record

ArticleInternational journal of molecular sciences2026

Antitumor Evaluation of Rhenium-188 and Paclitaxel Co-Delivered via Thermosensitive Hydrogel in a Hepatocellular Carcinoma Animal Model.

Ying-Hsia Shih, Cheng-Liang Peng, Ping-Fang Chiang, Chun-Tang Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ying-Hsia ShihDepartment of Isotope Application Research, National Atomic Research Institute, P.O. Box 3-27, Longtan, Taoyuan 32546, Taiwan.ORCID 0000-0002-3832-6132
Cheng-Liang PengDepartment of Isotope Application Research, National Atomic Research Institute, P.O. Box 3-27, Longtan, Taoyuan 32546, Taiwan.ORCID 0000-0001-7130-0260
Ping-Fang ChiangDepartment of Isotope Application Research, National Atomic Research Institute, P.O. Box 3-27, Longtan, Taoyuan 32546, Taiwan.
Chun-Tang ChenDepartment of Isotope Application Research, National Atomic Research Institute, P.O. Box 3-27, Longtan, Taoyuan 32546, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) remains one of the most common malignancies worldwide and a leading cause of cancer-related mortality. Current treatment options for advanced or unresectable HCC have limited efficacy and are often associated with systemic toxicity. In this study, a multifunctional, thermosensitive hydrogel-based delivery system was developed to enhance localized treatment of HCC. This system incorporates rhenium-188 sulfur colloid (

Indexed as

Antineoplastic AgentsCarcinoma, HepatocellularHydrogelsLiver NeoplasmsPaclitaxelRadioisotopesRheniumAnimalsCell Line, TumorDisease Models, AnimalDrug Delivery SystemsHumansMaleMiceMicellesTissue DistributionAntineoplastic AgentsHydrogelsMicellesPaclitaxelRadioisotopesRheniumRhenium-188hydrogelpaclitaxelrhenium-188unresectable HCC

Identifiers

PMID41596425
PMCPMC12841131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.